In-Use Test of a Cosmetic Product in Subjects With Chronically Itchy Scalp
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03630107 |
|
Recruitment Status :
Completed
First Posted : August 14, 2018
Last Update Posted : August 14, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
The aim of the study is to evaluate the tolerance of the Shampoo (WO 5101) on the scalp by a dermatologist and by the subjects themselves after four weeks of regular product use.
Additional objective of this clinical in-use study was to evaluate the cosmetic features and the acceptance of the product by means of a questionnaire at the end of the 4-week treatment period.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Pruritus of the Scalp | Other: WO 5101 Shampoo for Scalp and Hair | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 34 participants |
| Allocation: | N/A |
| Intervention Model: | Single Group Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | In-Use Test of a Shampoo (WO 5101) in Subjects With Pruritus of the Scalp |
| Actual Study Start Date : | February 15, 2018 |
| Actual Primary Completion Date : | March 15, 2018 |
| Actual Study Completion Date : | March 15, 2018 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: WO 5101 Shampoo for Scalp and Hair
WO 5101 is used in subjects with chronically itchy scalp
|
Other: WO 5101 Shampoo for Scalp and Hair
Wash the hair at least three times a week for a period of four weeks |
- Dermatological Tolerance of the Test Product on the Scalp [ Time Frame: baseline, four weeks ]
Change from Baseline at four weeks by the means of a dermatological assessment of scalp
- erythema
- edema
- dryness
- scaliness
- papules
- pustules
- fissures
- pruritus
- burning
- Tension
all Parameters (a-j) were assessed by 6-tiered rating scale with 0.5 intervals (0=absent; 0.5=very slight, 1/1.5= slight; 2/2.5=moderate; 3/3.5=severe and 4=extreme)
- Subjective Tolerance of the Test Product on the Scalp [ Time Frame: baseline, four weeks ]Change from baseline at four weeks by means of a self-assessment questionnaire (with 13 questions regarding cosmetic features of the product as well as satisfaction with cosmetic performance).
- Cosmetic Features of the Test Product [ Time Frame: baseline, four weeks ]Change from Baseline for the Cosmetic Features (scalp feeling after application, fragrance, hair styling, combability, lightness of the hair) of the Test Product by the means of a questionnaire
- Reduction of Pruritus [ Time Frame: baseline, four weeks ]Change from Baseline Reduction of Pruritus at four weeks by the means of a questionnaire
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- age: ≥ 18 years
- with chronically itchy scalp
- normal to dry scalp or scalp prone to neurodermatitis
Exclusion Criteria:
- any deviation from the above-mentioned criteria
- users of sour hair conditioner
- subjects who wash their hair more than once a day
- other dermatological disorders (scars, moles) on the scalp
- known incompatibilities to cosmetics and ingredients of cosmetic test products (please see INCI)
- topical medication in the test area within 1 month prior to study start
- systemic medication with anti-inflammatory agents and antibiotics within two weeks prior to starting of the study
- systemic medication with retinoids, antihistamines and/or immunomodulators (e.g. cortisone, corticosterone, chemotherapeutic agents) within four weeks prior to starting of the study
- severe internistic disease that leads to pruritus
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03630107
| Germany | |
| SIT Skin Investigation and Technology Hamburg GmbH | |
| Hamburg, Germany, 20354 | |
| Study Director: | Kerstin Söhl, MD | Dermatologist |
| Responsible Party: | Dr. August Wolff GmbH & Co. KG Arzneimittel |
| ClinicalTrials.gov Identifier: | NCT03630107 |
| Other Study ID Numbers: |
LPS-05/2017 |
| First Posted: | August 14, 2018 Key Record Dates |
| Last Update Posted: | August 14, 2018 |
| Last Verified: | August 2018 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
itchy scalp chronic pruritus |
|
Pruritus Skin Diseases Skin Manifestations |

